318 related articles for article (PubMed ID: 30059892)
21. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
[TBL] [Abstract][Full Text] [Related]
22. Hybridization-based design of novel anticholinesterase indanone-carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies.
Shahrivar-Gargari M; Hamzeh-Mivehroud M; Hemmati S; Mojarrad JS; Tüylü Küçükkılınç T; Ayazgök B; Dastmalchi S
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000453. PubMed ID: 33872422
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
[TBL] [Abstract][Full Text] [Related]
24. Novel dehydroabietylamine derivatives as potent inhibitors of acetylcholinesterase.
Wiemann J; Loesche A; Csuk R
Bioorg Chem; 2017 Oct; 74():145-157. PubMed ID: 28797788
[TBL] [Abstract][Full Text] [Related]
25. Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase.
Yu QS; Atack JR; Rapoport SI; Brossi A
FEBS Lett; 1988 Jul; 234(1):127-30. PubMed ID: 3391264
[TBL] [Abstract][Full Text] [Related]
26. Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesterase.
Heller L; Kahnt M; Loesche A; Grabandt P; Schwarz S; Brandt W; Csuk R
Eur J Med Chem; 2017 Jan; 126():652-668. PubMed ID: 27936444
[TBL] [Abstract][Full Text] [Related]
27. Novel 12-hydroxydehydroabietylamine derivatives act as potent and selective butyrylcholinesterase inhibitors.
Loesche A; Wiemann J; Rohmer M; Brandt W; Csuk R
Bioorg Chem; 2019 Sep; 90():103092. PubMed ID: 31280014
[TBL] [Abstract][Full Text] [Related]
28. Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
Krátký M; Vinšová J
Bioorg Med Chem; 2016 Mar; 24(6):1322-30. PubMed ID: 26879856
[TBL] [Abstract][Full Text] [Related]
29. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
30. Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE.
Magar P; Parravicini O; Štěpánková Š; Svrčková K; Garro AD; Jendrzejewska I; Pauk K; Hošek J; Jampílek J; Enriz RD; Imramovský A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502357
[TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.
Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS
Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155
[TBL] [Abstract][Full Text] [Related]
32. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
[TBL] [Abstract][Full Text] [Related]
34. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
[TBL] [Abstract][Full Text] [Related]
35. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
36. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study.
Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J
Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI
Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of readily available fluorophenylalanine derivatives and investigation of their biological activity.
Krátký M; Štěpánková Š; Vorčáková K; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
Bioorg Chem; 2017 Apr; 71():244-256. PubMed ID: 28245905
[TBL] [Abstract][Full Text] [Related]
39. Cholinesterase inhibitory alkaloids from the rhizomes of Coptis chinensis.
Cao TQ; Ngo QT; Seong SH; Youn UJ; Kim JA; Kim J; Kim JC; Woo MH; Choi JS; Min BS
Bioorg Chem; 2018 Apr; 77():625-632. PubMed ID: 29502023
[TBL] [Abstract][Full Text] [Related]
40. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
Więckowska A; Bajda M; Guzior N; Malawska B
Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
